ResMed Inc. Common Stock (NY:RMD)

218.89 -2.26 (-1.02%)

Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Stocks Mixed As Investors Take Big Tech Profits ↗

June 24, 2024

The major benchmarks are mixed today, as investors cycle out of the outperforming tech sector and buy into bank and energy stocks.

Via Talk Markets

Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again ↗

June 24, 2024

Eli Lilly tested its weight-loss drug in people with obesity suffering from sleep apnea events.

Via Investor's Business Daily

Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell' ↗

June 24, 2024

The U.S.

Via Benzinga

Topics Stocks

(RMD) - Analyzing ResMed's Short Interest ↗

June 20, 2024

Via Benzinga

If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today ↗

June 17, 2024

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

May 27, 2024

Via Benzinga

$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today ↗

May 17, 2024

Via Benzinga

(RMD) - Analyzing ResMed's Short Interest ↗

April 30, 2024

Via Benzinga

Elliott Wave Technical Forecast: Unlocking ASX Trading Success: ResMed Inc ↗

June 17, 2024

The analysis aims to provide readers with insights into the current market trends and how to capitalize on them effectively.

Via Talk Markets

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

June 10, 2024

ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA

From ResMed Inc.

Via GlobeNewswire

Stryker Stock Sees RS Rating Treks Higher To 71 ↗

May 29, 2024

Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71.

Via Investor's Business Daily

$100 Invested In ResMed 20 Years Ago Would Be Worth This Much Today ↗

May 29, 2024

Via Benzinga

Why ResMed Stock Is Soaring Today ↗

April 26, 2024

Investors liked the healthcare technology company's latest quarterly update.

Via The Motley Fool

Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provides Evidence of the Effectiveness and Critical Role of Positive Airway Pressure Therapy

May 23, 2024

From ResMed Inc.

Via GlobeNewswire

Betting on Nvidia: 3 ETFs to Own for Exposure to the AI Giant ↗

May 23, 2024

Explore three ETFs with Nvidia exposure to capitalize on the future of AI without having to pick a single winner.

Via InvestorPlace

Topics Artificial Intelligence ETFs

ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and Critical Role of PAP Therapy

May 16, 2024

From ResMed Inc.

Via GlobeNewswire

MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access

May 16, 2024

The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes.

From MatrixCare

Via GlobeNewswire

All-Time Highs In Sight: The Critical Signals You Can't Ignore ↗

May 15, 2024

Is the S&P 500 showing signs of a sustainable rally, or are we headed for a pullback?

Via Talk Markets

Topics Stocks

ResMed Announces Participation in the RBCCM Global Healthcare Conference

May 07, 2024

From ResMed Inc.

Via GlobeNewswire

Top Research Reports For Apple, Linde & Comcast ↗

May 06, 2024

Today's Research Daily features new research reports on 16 major stocks, including Apple Inc. (AAPL), Linde plc (LIN) and Comcast Corporation (CMCSA).

Via Talk Markets

Inspire Medical Systems Stock Sees IBD RS Rating Rise To 78 ↗

April 30, 2024

On Tuesday, Inspire Medical Systems stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 78.

Via Investor's Business Daily

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 26, 2024

Via Benzinga

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday ↗

April 26, 2024

Via Benzinga

ResMed Soars To Eight-Month High As Quarterly Report Wipes Out Weight-Loss Woes ↗

April 26, 2024

ResMed is the biggest maker of CPAPs in the U.S., and says the growing popularity of weight-loss drugs could help diagnosis rates.

Via Investor's Business Daily

ResMed Analysts Boost Their Forecasts After Better-Than-Expected Earnings ↗

April 26, 2024

Via Benzinga

Why Alphabet Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket ↗

April 26, 2024

Via Benzinga

Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn't Over Yet ↗

April 26, 2024

Tech earnings could come to the market’s rescue as traders remain jittery about the outcome of key inflation data due on Friday.

Via Benzinga

Topics Economy

RMD Stock Earnings: ResMed Beats EPS, Beats Revenue for Q3 2024 ↗

April 25, 2024

RMD stock results show that ResMed beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 25, 2024

Via Benzinga

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

April 25, 2024

From ResMed Inc.

Via GlobeNewswire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.